Malaria and Sickle Cell Disease Treatment Market, By Disease (Malaria and Sickle cell disease), By Drug Type, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Malaria and Sickle Cell Disease Treatment Market size was valued at USD 5,611.36 million in 2023, expanding at a CAGR of 25.9% from 2024 to 2032.
Malaria and Sickle Cell Disease Treatment Market Dynamics
The Malaria and Sickle Cell Disease Treatment Market focuses on developing and providing therapies and interventions to combat malaria and manage sickle cell disease. The persistent global burden of malaria, particularly in tropical and subtropical regions, is driving investments in research and development for innovative treatments and preventive measures. Additionally, the growing prevalence of sickle cell disease, especially in regions with high malaria transmission rates, further fuels market growth, prompting efforts to enhance disease management and develop curative therapies. However, challenges such as drug resistance in malaria treatment and the complexity of sickle cell disease management, compounded by limited access to healthcare in resource-constrained settings, may restrain market expansion. Nevertheless, opportunities abound with advancements in precision medicine and gene therapy, promising novel approaches for personalized treatment and potential cures, thereby driving innovation and market expansion in the malaria and sickle cell disease treatment landscape.
Advancements in Treating Malaria and Sickle Cell Disease Amidst High Prevalence
Advancements in treating malaria and sickle cell disease amidst high prevalence are crucial for addressing the significant global health burden posed by these conditions. For instance, according to the World Health Organization (WHO), malaria affects over 200 million people worldwide annually. Additionally, the Sickle Cell Disease Coalition estimates that approximately 300,000 children are born annually with sickle cell disease (SCD) worldwide, with this number expected to increase to 400,000 by 2050. In response, organizations like the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are investing in research initiatives aimed at developing innovative treatments and preventive strategies. Recent breakthroughs include the approval of new antimalarial drugs like tafenoquine and the emergence of promising gene-editing therapies for sickle cell disease, underscoring the potential of advancements in healthcare to alleviate the burden of these diseases on affected populations worldwide.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
AbbVie Inc.
Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
Bluebird Bio Inc.
Celgene Corporation (acquired by Bristol Myers Squibb)
Emmaus Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd
Gilead Sciences, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MacroGenics, Inc.
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Sobi
Vertex Pharmaceuticals Incorporated
Others
GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032
Malaria
Sickle cell disease
GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
Antimalarial Drugs
Pain Management Drugs
Disease-Modifying Therapies
Other
GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Parenteral
GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Malaria and Sickle Cell Disease Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Malaria and Sickle Cell Disease Treatment Market Snippet by Disease
2.1.2. Malaria and Sickle Cell Disease Treatment Market Snippet by Drug Type
2.1.3. Malaria and Sickle Cell Disease Treatment Market Snippet by Route of Administration
2.1.4. Malaria and Sickle Cell Disease Treatment Market Snippet by Country
2.1.5. Malaria and Sickle Cell Disease Treatment Market Snippet by Region
2.2. Competitive Insights
3. Malaria and Sickle Cell Disease Treatment Key Market Trends
3.1. Malaria and Sickle Cell Disease Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Malaria and Sickle Cell Disease Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Malaria and Sickle Cell Disease Treatment Market Opportunities
3.4. Malaria and Sickle Cell Disease Treatment Market Future Trends
4. Malaria and Sickle Cell Disease Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Malaria and Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Malaria and Sickle Cell Disease Treatment Market Landscape
6.1. Malaria and Sickle Cell Disease Treatment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Malaria and Sickle Cell Disease Treatment Market – By Disease
7.1. Overview
7.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
7.1.2. Malaria
7.1.3. Sickle cell disease
8. Malaria and Sickle Cell Disease Treatment Market – By Drug Type
8.1. Overview
8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
8.1.2. Antimalarial Drugs
8.1.3. Pain Management Drugs
8.1.4. Disease-Modifying Therapies
8.1.5. Other
9. Malaria and Sickle Cell Disease Treatment Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
9.1.2. Oral
9.1.3. Parenteral
10. Malaria and Sickle Cell Disease Treatment Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Malaria and Sickle Cell Disease Treatment Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. AbbVie Inc.
11.2.2. Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
11.2.3. Bluebird bio Inc.
11.2.4. Celgene Corporation (acquired by Bristol Myers Squibb)
11.2.5. Emmaus Pharmaceuticals, Inc.
11.2.6. F. Hoffmann-La Roche Ltd
11.2.7. Gilead Sciences, Inc.
11.2.8. GlaxoSmithKline plc
11.2.9. Johnson & Johnson
11.2.10. MacroGenics, Inc.
11.2.11. Merck & Co., Inc.
11.2.12. Novartis International AG
11.2.13. Pfizer Inc.
11.2.14. Sanofi S.A.
11.2.15. Sobi
11.2.16. Vertex Pharmaceuticals Incorporated
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
